{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T21:58:26Z","timestamp":1648850306936},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1097\/mjt.0b013e31816b9012","type":"journal-article","created":{"date-parts":[[2009,1,13]],"date-time":"2009-01-13T08:13:54Z","timestamp":1231834434000},"page":"44-55","source":"Crossref","is-referenced-by-count":0,"title":["An Update on Contraceptive Therapy Options"],"prefix":"10.1097","volume":"16","author":[{"given":"Mitzi","family":"Wasik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-9-20210202","first-page":"231207","article-title":"Pharm Lett.","volume":"23","year":"2007","journal-title":""},{"key":"R4-9-20210202","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0010-7824(03)00141-0","article-title":"The Seasonale- 301 Study Group. A multicenter, randomized study of an extended cycle oral contraceptive.","volume":"68","author":"Anderson","year":"2003","journal-title":"Contraception"},{"key":"R5-9-20210202","first-page":"77","article-title":"Three new combination oral contraceptives: Seasonique, Loestrin 24 Fe, and Yaz.","volume":"48","year":"2006","journal-title":"Med Lett Drugs Ther"},{"key":"R6-9-20210202","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.contraception.2005.09.010","article-title":"Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol.","volume":"73","author":"Anderson","year":"2006","journal-title":"Contraception"},{"key":"R8-9-20210202","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/GRF.0b013e318159c2f6","article-title":"The contraceptive implant.","volume":"50","author":"Hohmann","year":"2007","journal-title":"Clin Obstet Gynecol"},{"key":"R9-9-20210202","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/00002018-200326050-00002","article-title":"Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.","volume":"26","author":"Sivin","year":"2003","journal-title":"Drug Saf"},{"key":"R14-9-20210202","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2006.08.004","article-title":"Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg\/ethinyl estradiol 20 g (LoestrinR 24 Fe).","volume":"75","author":"Nakajima","year":"2007","journal-title":"Contraception"},{"key":"R16-9-20210202","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/01.AOG.0000175834.77215.2e","article-title":"Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder.","volume":"106","author":"Yonkers","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R18-9-20210202","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.2165\/00003495-200464210-00006","article-title":"Long-cycle treatment with oral contraceptives.","volume":"64","author":"Wiegratz","year":"2004","journal-title":"Drugs"},{"key":"R19-9-20210202","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.contraception.2006.07.005","article-title":"Evaluation of a continuous regimen of levonorgestrel\/ethinyl estradiol: phase 3 study results.","volume":"74","author":"Archer","year":"2006","journal-title":"Contraception"},{"key":"R20-9-20210202","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0010-7824(02)00445-6","article-title":"Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial.","volume":"67","author":"Kwiecien","year":"2003","journal-title":"Contraception"},{"key":"R21-9-20210202","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.contraception.2007.01.014","article-title":"Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen.","volume":"75","author":"Coffee","year":"2007","journal-title":"Contraception"},{"key":"R22-9-20210202","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0020-7292(99)00214-3","article-title":"A 10-year follow up study of contraceptive Norplant implants.","volume":"68","author":"Du","year":"2000","journal-title":"Int J Gynaecol Obstet"},{"issue":"Suppl","key":"R23-9-20210202","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0015-0282(01)03275-7","article-title":"Contraceptive efficacy and cycle control with the Ortho Evra\/Evra transdermal system: The analysis of pooled data.","volume":"77","author":"Zieman","year":"2002","journal-title":"Fertil Steril"},{"key":"R24-9-20210202","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/aje\/kwm221","article-title":"Obesity and oral contraceptive failure: findings from the 2002 National Survey of Family Growth.","volume":"166","author":"Brunner Huber","year":"2007","journal-title":"Am J Epidemiol"},{"key":"R25-9-20210202","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10995-005-0015-5","article-title":"The association between body weight, unintended pregnancy resulting in a livebirth, and contraception at the time of conception.","volume":"9","author":"Brunner Huber","year":"2005","journal-title":"Matern Child Health J"},{"key":"R26-9-20210202","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.annepidem.2006.01.001","article-title":"Body mass index and risk for oral contraceptive failure: a case-cohort study in South Carolina.","volume":"16","author":"Brunner Huber","year":"2006","journal-title":"Ann Epidemiol"},{"key":"R27-9-20210202","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/00006250-200606000-00055","article-title":"ACOG Practice Bulletin. No. 73. Use of hormonal contraception in women with coexisting medical conditions.","volume":"107","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R28-9-20210202","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/13625180600815706","article-title":"Risk of cancer development in relation to oral contraception.","volume":"11","author":"Lech","year":"2006","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R30-9-20210202","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/aje\/kwm157","article-title":"Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk.","volume":"166","author":"Tworoger","year":"2007","journal-title":"Am J Epidemiol"},{"key":"R31-9-20210202","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/aje\/kwi162","article-title":"Short-term oral contraceptive use and the risk of epithelial ovarian cancer.","volume":"162","author":"Greer","year":"2005","journal-title":"Am J Epidemiol"},{"key":"R32-9-20210202","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/01.AOG.0000255664.48970.e6","article-title":"Association of estrogen and progestin potency of oral contraceptives with ovarian carcinoma risk.","volume":"109","author":"Lurie","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R33-9-20210202","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls.","volume":"371","year":"2008","journal-title":"Lancet"},{"key":"R34-9-20210202","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.contraception.2004.08.003","article-title":"Use of exogenous hormones by women and colorectal cancer: evidence from the Royal College of General Practitioners Oral Contraception Study.","volume":"71","author":"Hannaford","year":"2005","journal-title":"Contraception"},{"key":"R35-9-20210202","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women.","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"R36-9-20210202","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0002-9343(99)00063-7","article-title":"Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis.","volume":"106","author":"Grodstein","year":"1999","journal-title":"Am J Med"},{"key":"R37-9-20210202","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1470-2045(05)70273-4","article-title":"Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment.","volume":"6","author":"Cogliano","year":"2005","journal-title":"Lancet Oncol"},{"key":"R38-9-20210202","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(07)61684-5","article-title":"Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16573 women with cervical cancer and 35509 women without cervical cancer from 24 epidemiological studies.","volume":"370","year":"2007","journal-title":"Lancet"},{"key":"R39-9-20210202","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(03)12949-2","article-title":"Cervical cancer and use of hormonal contraceptives: a systematic review.","volume":"361","author":"Smith","year":"2003","journal-title":"Lancet"},{"key":"R40-9-20210202","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3322\/canjclin.52.6.342","article-title":"American Cancer Society guideline for the early detection of cervical neoplasia and cancer.","volume":"52","author":"Saslow","year":"2002","journal-title":"CA Cancer J Clin"},{"key":"R41-9-20210202","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies.","volume":"347","year":"1996","journal-title":"Lancet"},{"key":"R42-9-20210202","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1158\/1055-9965.EPI-04-0376","article-title":"Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations.","volume":"14","author":"Milne","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"Suppl 1","key":"R43-9-20210202","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.ajog.2004.01.061","article-title":"Safety concerns and health benefits associated with oral contraception.","volume":"190","author":"Burkman","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R44-9-20210202","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0010-7824(98)00018-3","article-title":"Safety evaluation of modern oral contraceptives. Effects on lipoprotein and carbohydrate metabolism.","volume":"57","author":"Crooks","year":"1998","journal-title":"Contraception"},{"key":"R45-9-20210202","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0010-7824(03)00073-8","article-title":"Oral contraceptives use and the risk of myocardial infarction: a meta-analysis.","volume":"68","author":"Khader","year":"2003","journal-title":"Contraception"},{"key":"R46-9-20210202","first-page":"1202","article-title":"WHO collaborative study of cardiovascular disease and steroid hormone contraception.","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"R47-9-20210202","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/bmj.298.6667.165","article-title":"Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners oral contraceptive study.","volume":"298","author":"Croft","year":"1989","journal-title":"BMJ"},{"key":"R48-9-20210202","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/j.1552-4604.1963.tb00314.x","article-title":"The final Enovid report.","volume":"3","year":"1963","journal-title":"J New Drugs"},{"key":"R49-9-20210202","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/13625180701300194","article-title":"Combined hormonal contraception and venous thromboembolism.","volume":"12","author":"Martinez","year":"2007","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R50-9-20210202","first-page":"1575","article-title":"World Health Organization collaborative study of cardiovascular diseases and steroid hormone contraception.","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"R52-9-20210202","first-page":"1","article-title":"Third generation oral contraceptives and risk of venous thrombosis: meta-analysis.","volume":"323","author":"Kemmermen","year":"2001","journal-title":"BMJ"},{"key":"R54-9-20210202","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(95)12394-6","article-title":"Hemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative study of cardiovascular disease and steroid hormone contraception.","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"R55-9-20210202","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1474-4422(04)00819-1","article-title":"Oral contraceptives and stroke risk: the debate continues.","volume":"3","author":"Gillum","year":"2004","journal-title":"Lancet"},{"key":"R56-9-20210202","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/archinte.164.7.741","article-title":"Risk of stroke in women exposed to low-dose oral contraceptives.","volume":"164","author":"Chan","year":"2004","journal-title":"Arch Intern Med"},{"key":"R57-9-20210202","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jama.284.1.72","article-title":"Ischemic stroke risk with oral contraceptives.","volume":"284","author":"Gillum","year":"2000","journal-title":"JAMA"},{"key":"R59-9-20210202","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.contraception.2006.01.001","article-title":"Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 g of ethinyl estradiol.","volume":"73","author":"Jick","year":"2006","journal-title":"Contraception"},{"key":"R60-9-20210202","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/01.AOG.0000250968.82370.04","article-title":"Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.","volume":"109","author":"Cole","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R63-9-20210202","first-page":"1290","article-title":"Contraceptive use and discontinuation; findings from the contraceptive history, initiation, and choice study.","volume":"194","author":"Brunner Huber","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R64-9-20210202","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0010-7824(95)00074-K","article-title":"Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation.","volume":"51","author":"Rosenberg","year":"1995","journal-title":"Contraception"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00045391-200901000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:39:51Z","timestamp":1618036791000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-200901000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e31816b9012","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}